Symcel AB

https://www.symcel.com

Symcel provides a novel cell-based assay tool for real-time cellular bioactivity measurements. Our solution is a fast label-free phenotypic screening technology for direct measurements of cell metabolism that provides powerful answers to whether cells are dead or alive. Symcel is a privately held biotechnology company located in Stockholm Sweden. Symcel was founded in 2004 by Dr. Dan Hallén and Prof. Ingemar Wadsö (Kemicentrum, Lund University). Dr Wadsö is a leading authority around bioactivity measurements and has together with colleagues at Lund University been instrumental in the development of the field. The current research team at Symcel has extensive experience in multiple disciplines within the biotechnology industry as well as the pharmaceutical development industry. *

	Start	2004-01-01 established
	Industry	cell-based assay (research)
	Person	Ericsson, Jesper (Symcel AB 201709– CEO before Karolinska Institutet)
	Person 2	Walldén, Erik (Gyros 200903–201310 CEO RESIGNED 10/13 before Affibody CEO + Biacore CEO + Pyrosequencing CEO)

	Region	Sweden_oo
	Country	Sweden
	Street	4 Domnarvsgatan
	City	16353 Spånga
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Symcel AB. (6/27/18). "Press Release: New Board Members Bolstering Expansion into Diagnostics Market".

		Record changed: 2024-02-12